美国 · 财经报刊 · Investor's Business Daily
Novo Surges 5% After Walloping Expectations On The Back Of Its GLP-1 Drugs
Novo stock popped early Wednesday on better-than-expected third-quarter sales and profit thanks to resounding beats from its GLP-1 drugs. The post Novo Surges 5% After Walloping…
在 Investor's Business Daily 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.investors.com)